Terminal-restriction fragment length polymorphism (T-RFLP) analysis for changes in the gut microbiota profiles of indomethacin- and rebamipide-treated mice.
about
A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damageSpecific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats.Rebamipide Alters the Esophageal Microbiome and Reduces the Incidence of Barrett's Esophagus in a Rat Model.Administration of Non-Absorbable Antibiotics to Pregnant Mice to Perturb the Maternal Gut Microbiota Is Associated with Alterations in Offspring Behavior.Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.Gut Microbiota Mediates Protection Against Enteropathy Induced by Indomethacin.Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model.The non-invasive exfoliated transcriptome (exfoliome) reflects the tissue-level transcriptome in a mouse model of NSAID enteropathy.
P2860
Q28546385-B0134463-4E02-4CFF-9609-744E7AB3CDC4Q35102353-AA48D66A-964C-4BB7-99C1-0EC4C32CABD2Q35599452-3FA5027B-3FF3-4989-904A-22C7ECA8B31CQ35899043-0D8B5690-973F-4E04-9F9A-11FC33D36EB8Q36239612-7326D63D-8B21-4B74-A949-B1397DC8058AQ38773030-CF59EC85-3DE2-4E10-A24E-FB127190EAFDQ41361724-4E675B8F-DA14-4187-B0CA-1842C771C375Q42778368-D11C235D-1B4D-4AE9-A8C1-0F3A2A31AD13
P2860
Terminal-restriction fragment length polymorphism (T-RFLP) analysis for changes in the gut microbiota profiles of indomethacin- and rebamipide-treated mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Terminal-restriction fragment ...... - and rebamipide-treated mice.
@en
Terminal-restriction fragment length polymorphism
@nl
type
label
Terminal-restriction fragment ...... - and rebamipide-treated mice.
@en
Terminal-restriction fragment length polymorphism
@nl
prefLabel
Terminal-restriction fragment ...... - and rebamipide-treated mice.
@en
Terminal-restriction fragment length polymorphism
@nl
P2093
P2860
P356
P1433
P1476
Terminal-restriction fragment ...... n- and rebamipide-treated mice
@en
P2093
Akira Andoh
Eiji Kasumi
Kenichiro Takahashi
Takehide Fujimoto
Yoshihide Fujiyama
P2860
P304
P356
10.1159/000341508
P577
2012-09-07T00:00:00Z